<6aS-(6aα,9aα,10β)13aS>-1,10-methano-4-hydroxy-11-methyl-6,6a,10,11,12,13-hexahydro-<1>-benzopyrano<4,3-e>isoquinoline-7-(9aH)-one | 159854-09-8

• 分子结构分类: 有机化合物 - 生物碱及其衍生物 - 吗啡烷
• 英文名称: <6aS-(6aα,9aα,10β)13aS>-1,10-methano-4-hydroxy-11-methyl-6,6a,10,11,12,13-hexahydro-<1>-benzopyrano<4,3-e>isoquinoline-7-(9aH)-one
• 英文别名: [6aS-(6aα,9aα,10β)13aS]-1,10-methano-4-hydroxy-11-methyl-6,6a,10,11,12,13-hexahydro-[1]-benzpyrano[4,3-e]isoquinoline-7-(9aH)-one；(1R,5R,14S,18R)-10-hydroxy-4-methyl-12-oxa-4-azapentacyclo[9.7.1.01,14.05,18.07,19]nonadeca-7(19),8,10,16-tetraen-15-one
• CAS: 159854-09-8
• 化学式: C₁₈H₁₉NO₃
• 分子量: 297.354
• InChiKey: JENRSPSMXHHSKA-ZVZLLHMNSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.8
• 重原子数：
  22
• 可旋转键数：
  0
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  49.8
• 氢给体数：
  1
• 氢受体数：
  4

反应信息

• 作为反应物：
  描述：

  <6aS-(6aα,9aα,10β)13aS>-1,10-methano-4-hydroxy-11-methyl-6,6a,10,11,12,13-hexahydro-<1>-benzopyrano<4,3-e>isoquinoline-7-(9aH)-one 在 Rh/Al₂O₃ 氢气 作用下， 以 乙酸乙酯 为溶剂， 反应 17.0h， 以71%的产率得到[6aS-(6aα,9aα,10β)13aS]-1,10-methano-4-hydroxy-11-methyl-6,6a,8,9,10,11,12,13-octahydro-[1]-benzpyrano[4,3-e]isoquinoline-7-(9aH)-one
  参考文献：
  名称：

  Metopon和两种独特的衍生物：对多种阿片受体的亲和力和选择性。

  摘要：

  5β-甲基-7,8-二氢吗啡酮（甲氧磷），一种异构体[6aS-（6a alpha，9a alpha，10 beta）13aS] -1,10-methano-4-hydroxy-11-methyl- 6,6a，由5个β-甲基吗啡酮的光化学重排得到的8,9,10,11,12,13-八氢-[1]-苯并吡喃并[4,3，e]异喹啉-7-（9aH）-1（化合物1），和[6aS-（6a alpha，9a alpha，10 beta）13aS] -1,10-methano-4-hydroxy-11-methyl- 6,6a，8,9，10,11,12,13-octahydro-[ 1]-苯并吡喃并[4,3，e] -14β-（对硝基肉桂酰氨基）异喹啉-7-（9aH）-1（化合物2）的阿片受体亲和力，选择性和镇痛特性。在使用牛纹状体膜的竞争结合试验中，这三种化合物抑制了0.25 nM [3H] [D-Ala2，

  DOI：

  10.1016/0014-2999(95)00536-6
• 作为产物：
  描述：

  (-)-5β-methylcodeinone 在 三溴化硼 作用下， 以 甲醇 、 二氯甲烷 为溶剂， 反应 21.5h， 生成 <6aS-(6aα,9aα,10β)13aS>-1,10-methano-4-hydroxy-11-methyl-6,6a,10,11,12,13-hexahydro-<1>-benzopyrano<4,3-e>isoquinoline-7-(9aH)-one
  参考文献：
  名称：

  Photochemistry of Structurally-Modified Morphine Alkaloids

  摘要：

  N-Carbomethoxynorcodeinone (1b) was found to be unreactive to photolysis in benzene solution, but irradiation (366 nm) in the presence of methanol, water, ethanol, or n-propyl alcohol gave the rearranged and solvent-incorporated phenols 13a-d. Under comparable photolysis conditions, N-carbomethoxynordihydrocodeinone (33) did not photorearrange at 366 or > 300 nm. Spirocyclopropane 15b is proposed to be an intermediate in this photorearrangement; addition of ROH to 15b occurs by nucleophilic attack with inversion of configuration at the cyclopropane carbon atom most able to stabilize a positive charge. In the absence of a suitable nucleophile (benzene or t-BuOH solutions) 15b reverts to 1b. Irradiation of the C(5)-methyl-substituted codeinone derivative 17a in methanol solution did not result in solvent incorporation, but rather gave the benzopyran 21a in quantitative yield by way of the intermediate dienone 20a. The carbamate 17b gave separable mixtures of 20b and 21b; dienone 20b was converted to benzopyran 21b in quantitative yield by treatment with diethylamine in CH2Cl2. Additional examples of this tandem photorearrangement-hydrogen atom transfer-intramolecular conjugate addition are described; e.g., 22 --> 24 and 25 --> 26. Photolysis of 1b in the presence of acetic acid gives a mixture of the solvent-incorporated phenol 27 and 8,9-dihydro-2-methoxy-7-carbomethoxydibenz[d,f]azonine-1,13-diol (28). The less nucleophilic oxalic acid provides a route to 28 free of solvent-incorporated products analogous to 27. The facial specific photoadditions of THF to enones 13b and 1b to give 30 and 31 occur by hydrogen atom transfer from C(2) of THF to the photosubstrate followed by radical coupling at the beta-position of the enone. The molecular structure and novel crystal packing arrangement of the monohydrate of 30 were determined by an X-ray diffraction study. Enones 1b and 17b also undergo SET-type photoreductions in the presence of triethylamine (TEA) to give alpha-thebainone derivatives 32a and 32b. A mechanism is proposed to account for photoproduct distributions when irradiations are carried out in the presence of varying amounts of both methanol and TEA. It was found that codeine is as effective as TEA in promoting the photoreduction of 1b to the alpha-thebainone derivative 32a. Opportunities for the utilization of the photochemistry of modified morphine alkaloids for approaches to opiate receptor photoaffinity labeling and the provision of new substrates for opiate receptor affinity studies are briefly discussed.

  DOI：

  10.1021/ja00102a011

文献信息

• Photochemistry of Structurally-Modified Morphine Alkaloids
  作者：Arthur G. Schultz、David M. Graves、Neal J. Green、Richard R. Jacobson、Deanne M. Nowak

  DOI：10.1021/ja00102a011

  日期：1994.11

  N-Carbomethoxynorcodeinone (1b) was found to be unreactive to photolysis in benzene solution, but irradiation (366 nm) in the presence of methanol, water, ethanol, or n-propyl alcohol gave the rearranged and solvent-incorporated phenols 13a-d. Under comparable photolysis conditions, N-carbomethoxynordihydrocodeinone (33) did not photorearrange at 366 or > 300 nm. Spirocyclopropane 15b is proposed to be an intermediate in this photorearrangement; addition of ROH to 15b occurs by nucleophilic attack with inversion of configuration at the cyclopropane carbon atom most able to stabilize a positive charge. In the absence of a suitable nucleophile (benzene or t-BuOH solutions) 15b reverts to 1b. Irradiation of the C(5)-methyl-substituted codeinone derivative 17a in methanol solution did not result in solvent incorporation, but rather gave the benzopyran 21a in quantitative yield by way of the intermediate dienone 20a. The carbamate 17b gave separable mixtures of 20b and 21b; dienone 20b was converted to benzopyran 21b in quantitative yield by treatment with diethylamine in CH2Cl2. Additional examples of this tandem photorearrangement-hydrogen atom transfer-intramolecular conjugate addition are described; e.g., 22 --> 24 and 25 --> 26. Photolysis of 1b in the presence of acetic acid gives a mixture of the solvent-incorporated phenol 27 and 8,9-dihydro-2-methoxy-7-carbomethoxydibenz[d,f]azonine-1,13-diol (28). The less nucleophilic oxalic acid provides a route to 28 free of solvent-incorporated products analogous to 27. The facial specific photoadditions of THF to enones 13b and 1b to give 30 and 31 occur by hydrogen atom transfer from C(2) of THF to the photosubstrate followed by radical coupling at the beta-position of the enone. The molecular structure and novel crystal packing arrangement of the monohydrate of 30 were determined by an X-ray diffraction study. Enones 1b and 17b also undergo SET-type photoreductions in the presence of triethylamine (TEA) to give alpha-thebainone derivatives 32a and 32b. A mechanism is proposed to account for photoproduct distributions when irradiations are carried out in the presence of varying amounts of both methanol and TEA. It was found that codeine is as effective as TEA in promoting the photoreduction of 1b to the alpha-thebainone derivative 32a. Opportunities for the utilization of the photochemistry of modified morphine alkaloids for approaches to opiate receptor photoaffinity labeling and the provision of new substrates for opiate receptor affinity studies are briefly discussed.
• Metopon and two unique derivatives: affinity and selectivity for the multiple opioid receptors
  作者：Jay P. McLaughlin、Deanne Nowak、Alice Sebastian、Arthur G. Schultz、Sydney Archer、Jean M. Bidlack

  DOI：10.1016/0014-2999(95)00536-6

  日期：1995.12

  5 beta-Methyl-7,8-dihydromorphinone (metopon), an isomer [6aS-(6a alpha,9a alpha, 10 beta)13aS]-1,10-methano-4-hydroxy-11-methyl- 6,6a,8,9,10,11,12,13-octahydro-[1]-benzopyrano[4,3,e]isoquinoline- 7-(9aH)-one (compound 1) derived from a photochemical rearrangement of 5 beta-methylmorphinone, and [6aS-(6a alpha,9a alpha,10 beta)13aS]-1,10-methano-4-hydroxy-11-methyl- 6,6a,8,9, 10,11,12,13-octahydro-[1]-benzopyrano[4

  5β-甲基-7,8-二氢吗啡酮（甲氧磷），一种异构体[6aS-（6a alpha，9a alpha，10 beta）13aS] -1,10-methano-4-hydroxy-11-methyl- 6,6a，由5个β-甲基吗啡酮的光化学重排得到的8,9,10,11,12,13-八氢-[1]-苯并吡喃并[4,3，e]异喹啉-7-（9aH）-1（化合物1），和[6aS-（6a alpha，9a alpha，10 beta）13aS] -1,10-methano-4-hydroxy-11-methyl- 6,6a，8,9，10,11,12,13-octahydro-[ 1]-苯并吡喃并[4,3，e] -14β-（对硝基肉桂酰氨基）异喹啉-7-（9aH）-1（化合物2）的阿片受体亲和力，选择性和镇痛特性。在使用牛纹状体膜的竞争结合试验中，这三种化合物抑制了0.25 nM [3H] [D-Ala2，